| Breakdown | TTM | Oct 2025 | Oct 2024 | Oct 2023 | Oct 2022 | Oct 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 24.54B | 24.16B | 21.61B | 17.99B | 14.54B | 12.13B |
| Gross Profit | 5.89B | 5.95B | 5.68B | 4.92B | 3.99B | 3.10B |
| EBITDA | 2.99B | 3.15B | 3.36B | 2.70B | 2.24B | 1.64B |
| Net Income | 1.93B | 2.09B | 2.19B | 1.74B | 1.24B | 1.04B |
Balance Sheet | ||||||
| Total Assets | 24.35B | 24.58B | 23.62B | 22.51B | 20.16B | 19.25B |
| Cash, Cash Equivalents and Short-Term Investments | 4.31B | 4.82B | 4.52B | 4.08B | 2.28B | 2.16B |
| Total Debt | 5.42B | 5.62B | 6.15B | 6.61B | 7.28B | 8.26B |
| Total Liabilities | 9.89B | 10.10B | 10.18B | 10.33B | 10.22B | 10.61B |
| Stockholders Equity | 14.45B | 14.48B | 13.44B | 12.18B | 9.93B | 8.63B |
Cash Flow | ||||||
| Free Cash Flow | 2.40B | 2.24B | 2.30B | 2.27B | 1.49B | 1.07B |
| Operating Cash Flow | 2.52B | 2.30B | 2.31B | 2.31B | 1.55B | 1.08B |
| Investing Cash Flow | -304.24M | -197.64M | -6.38M | 22.05M | -176.44M | -1.01B |
| Financing Cash Flow | -1.95B | -1.92B | -1.87B | -536.63M | -1.25B | 158.22M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
74 Outperform | ¥21.38B | 7.96 | ― | 2.97% | -9.99% | 58.24% | |
73 Outperform | ¥19.95B | 13.90 | ― | 3.59% | 1.02% | 7.04% | |
72 Outperform | ¥18.36B | 9.79 | ― | 5.04% | 9.01% | -17.58% | |
69 Neutral | ¥15.96B | 11.13 | ― | 0.56% | 3.95% | -18.58% | |
67 Neutral | ¥14.98B | 6.44 | ― | 3.03% | 24.82% | 23.42% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
62 Neutral | ¥18.22B | 46.87 | ― | 2.54% | -3.27% | 134.48% |